The United States DILIN criteria for assessing drug-induced liver injury utilizes broader criteria, including serum alkaline phosphatase >2 times the upper limit of normal, or jaundice or coagulopathy with elevated ALT or AST. This evidence concerns the gene GPT and Jaundice.